Nessan Bermingham - President & CEO, Intellia Therapeutics, Inc

As of December 14, 2017


Nessan Bermingham Net Worth

  • Net worth is estimated to be at least $129.04M
  • Owns at least 458,250 units of Intellia Therapeutics, Inc stock
  • Sold an estimated value of $7M in the last year at Intellia Therapeutics, Inc

Nessan Bermingham Trading

  • Largest sale of shares was 336,783 units , worth over $7M on December 8, 2017
  • In total has made about 5 transactions over a year
  • Usually trades in December, with the busiest year in 2017
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Nessan Bermingham Mailing Address

  • Mailing address is 890 Winter Street Waltham MA 02451 MA

Intellia Therapeutics, Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Stock Awards
Other Compensation
Total
John M. Leonard, M.D. 2020 $580,000 $319,000 $2,722,890 - $13,786 $3,635,676
John M. Leonard, M.D. 2019 $559,200 $307,560 - - $37,026 $903,786
John M. Leonard, M.D. 2018 $550,000 $302,500 $7,818,005 $1,011,713 $26,112 $9,708,330
Glenn G. Goddard 2020 $407,000 $146,520 $1,001,063 - $8,928 $1,563,511
Glenn G. Goddard 2019 $383,000 $153,200 - - $5,644 $541,844
Glenn G. Goddard 2018 $67,718 $51,652 $1,896,825 - $218 $2,016,413
David Lebwohl, M.D. 2020 $298,378 $228,000 $1,549,720 - $2,690 $2,078,788
Andrew D. Schiermeier, Ph.D. 2020 $455,400 $173,052 $1,081,148 - $8,928 $1,718,528
Andrew D. Schiermeier, Ph.D. 2019 $440,000 $167,200 $611,897 - $8,778 $1,227,875
Andrew D. Schiermeier, Ph.D. 2018 $408,934 $182,600 $2,028,554 $295,550 $9,668 $2,925,306
Laura Sepp-Lorenzino, Ph.D. 2020 $420,000 $184,800 $1,081,148 - $4,578 $1,690,526
Laura Sepp-Lorenzino, Ph.D. 2019 $239,487 $204,086 $1,318,695 - $221 $1,762,489
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1652130/000156459021021413/ntla-def14a_20210623.htm

Intellia Therapeutics, Inc Insider Trading

  • The most recent transaction was 2,400 units sold on September 23, 2021 by David Lebwohl worth over $359.54K
  • In the last 5 years, insiders at Intellia Therapeutics, Inc sold an estimated value of $303.34M and bought an estimated value of $43.6M
  • The most active traders are John Leonard, President and CEO,  Jose Rivera, EVP,  and Francois Jean Formela, Director
  • Insider trading is most common in May, with the busiest year in 2021

Intellia Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1